Abstract
According to our present knowledge, myocardial energy metabolism is not involved directly in the mode of action of cardiac glycosides. However, it is well known clinically that the therapeutic efficiency of these drugs is to a certain degree dependent on the metabolic state of the heart; they are most effective in hearts with no defects in energy metabolism such as congestive heart failure due to excessive hemodynamic pressure loads (e.g., hypertension, valvular lesions, arteriosclerotic diseases) whereas they are rather ineffective in cardiac failure due to anemia, hypoxia, thyrotoxicosis, and severe thiamine deficiency (beriberi) in which energy supply is impaired (Moe and Farah, 1975) and experimentally it has been shown that heart failure caused by poisons that reduce energy-rich phosphate pools (cyanide, dinitrophenol, etc.) is not relieved by digitalis (Gruiizit and Farah, 1955).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abiko, Y., Ichihara, K.: Effect of ouabain on myocardial metabolic and contractile responses to coronary ligation. Eur. J. Pharmacol. 47, 87–94 (1978)
Angkapindu, A., Stafford, A.W., Thorp, R.H.: The influence of cardiac glycosides on the deamination of adenosine and the adenine nucleotides. Arch. Int. Pharmacodyn. 119, 194–204 (1959)
Arcasoy, M.M., Smuckler, E.A.: Acute effect of digoxin intoxication on rat hepatic and cardiac cells. Lab. Invest. 20, 190–201 (1969)
Arese, P., Bosia, A., Rossini, L.: Short-term effects of ouabain on energy-rich, glycolytic, and citric-acid-cycle intermediates in frog heart. Biochem. Biophys. Res. Commun. 27, 138–142 (1967)
Arese, P., Bosia, A., Rossini, L.: Short-term effects of calcium, potassium, and of ouabain on metabolite levels in the frog heart in vivo. Eur. J. Biochem. 11, 80–88 (1969)
Arnold, G., Kosche, F., Miessner, E., Neitzert, A., Lochner, W.: The importance of the perfusion pressure in the coronary arteries for the contractility and the oxygen consumption of the heart. Pflügers Arch. 229, 339–356 (1968)
Arnold, G., Morgenstern, C., Lochner, W.: The autoregulation of the heart work by the coronary perfusion pressure. Pflügers Arch. 321, 34–55 (1970)
Bacaner, M.B., Lioy, F., Visscher, M.B.: Induced change in heart metabolism as a primary determinant of heart performance. Am. J. Physiol. 209, 519–531 (1965)
Bailey, L.E., Dresel, P.E.: Increase in the rate of onset of the inotropic response to ouabain due to insulin. Life Sci. 8, 347–351 (1969)
Bailey, L.E., Dresel, P.E.: Role of the sugar transport system in the positive inotropic response to digitalis. J. Pharmacol. Exp. Ther. 176, 538–544 (1971)
Benmouyal, E.: Effects of ions, ouabain, epinephrine, and tetrodotoxin on glucose metabolism and on contractility in perfused guinea pig heart. Can. J. Physiol. Pharmacol. 50, 584–593 (1972)
Bernsmeier, A., Rudolph, W.: Myokardstoffwechsel. Verh. Dtsch. Ges. Kreislaufforsch. 27, 59–76 (1961)
Bihler, I.: The action of cardiotonic steroids on sugar transport in muscle, in vitro. Biochim. Biophys. Acta (Amst.) 163, 401–410 (1968)
Bihler, I., Sawh, P.C.: The effect of oxidative metabolic substrates on the membrane transport of sugars and on the action of ouabain in skeletal muscle in vitro. Can. J. Physiol. Pharmacol. 51, 371–377 (1973)
Bihler, I., Sawh, P.C.: Sugar transport in the perifused left atrium: effect of contraction, frequency, digitalis, and ionic alterations. J. Mol. Cell. Cardiol. 7, 345–355 (1975a)
Bihler, I., Sawh, P.C.: A comparison of the effects of ouabain on sugar and sodium transport and on contractile activity of isolated atria. Proc. West. Pharmacol. Soc. 18, 106–109 (1975b)
Bihler, I., Sawh, P.C.: Regulation of sugar transport in the myocardium: effects of ouabain in resting and beating isolated guinea pig left atria. J. Mol. Cell. Cardiol. 11, 407–414 (1979)
Bing, R.J.: Metabolism of the heart. Harvey Lect. 50, 27–70 (1954)
Bing, R.J.: Über den Stoffwechsel des intakten Herzens. Verh. Dtsch. Ges. Kreislaufforsch. 27, 145–166 (1961)
Bing, R.J.: Cardiac metabolism. Physiol. Rev. 45, 171–213 (1965)
Bing, R.J., Maraist, F.M., Dammann, J.F., Draper, A., Heimbecker, R., Daley, R., Gerard, R., Calazel, P.: Effect of strophanthus on coronary blood flow and cardiac oxygen consumption of normal and failing human hearts. Circulation 2, 513–516 (1950)
Blain, J.M., Eddlemann, E.E., Siegel, A., Bing, R.J.: Studies on myocardial metabolism. V. The effects of lanatoside C on the metabolism of the human heart. J. Clin. Invest. 35, 314–321 (1956)
Boerth, R.C., Hammermeister, K.E., Warbasse, J.R.: Comparative influence of ouabain, norepinephrine, and heart rate on myocardial oxygen consumption and inotropic state in dogs. Am. Heart J. 96, 355–362 (1978)
Bogatzki, M.: Adenylpyrophosphatase in the myocardium under the influence of various pharmacological agents. Z. Ges. Exp. Med. 134, 454–460 (1961)
Bogatzki, M., Straub, H.: ATP-System and übriger Phosphatstoffwechsel im normalen and akut-insuffizienten Herzmuskel unter der Behandlung mit Herzglykosiden. Z. Ges. Exp. Med. 127, 425–449 (1956)
Boninsegna, A., Dominici, A.: Inotropic effect of cardiac phospholipids on the contraction of rabbit heart perfused with a calcium deficient medium. Biochem. Pharmacol. 21, 601–605 (1972)
Braunwald, E.: Control of myocardial oxygen consumption. Physiologic and clinical considerations. Am. J. Cardiol. 27, 416–432 (1971)
Braunwald, E., Bloodwell, R.D., Goldberg, L.T.: Studies on digitalis. IV. Observations in man on the effect of digitalis preparations on the contractility of the nonfailing heart and on total vascular resistance. J. Clin. Invest. 40, 52–59 (1961)
Braunwald, E., Ross, J. Jr., Sonnenblick, E.H.: Myocardial energetics. In: Mechanisms of contraction of the normal and failing heart, 2 nd. ed., pp. 166–199. Boston: Little, Brown and Company 1976
Bretschneider, H.J.: Uberlebenszeit and Wiederbelebungszeit des Herzens bei Normo-and Hypothermie. Verh. Dtsch. Ges. Kreislaufforsch. 30, 11–34 (1964)
Bretschneider, H.J.: Die hämodynamischen Determinanten des Sauerstoffbedarfes des Herzmuskels. Arzneim. Forsch. 21, 1515–1517 (1971)
Britman, N.A., Levine, H.J.: Contractile element work: a major determinant of myocardial oxygen consumption. J. Clin. Invest. 43, 1397–1408 (1964)
Bruce, T.A., Zobl, E.: Myocardial oxidative metabolism in normal subjects during ouabain administration. J. Lab. Clin. Med. 74, 855 (1969)
Bugge-Asperheim, B.: Effects of increased aortic blood pressure on myocardial performance and metabolism during non-adrenergic inotropic stimulation of the heart. Scand. J. Clin. Lab. Invest. 30, 137–143 (1972)
Burdette, W.J.: Increase in oxygen consumption of human cardiac muscle incubated with lanatosideC. J. Lab. Clin. Med. 40, 867–871 (1952)
Carafoli, E.: Mitochondria in the contraction and relaxation of heart. In: Myocardial biol-ogy. Dhalla, N.S. (ed.), pp. 393–406. Baltimore: University Park Press 1974
Caroni, P., Carafoli, E.: An ATP-dependent Ca++-pumping system in dog heart sarcolem-ma. Nature (Lond.) 283, 765–767 (1980)
Chance, B.: The energy-linked reaction of calcium with mitochondria. J. Biol. Chem. 240, 2729–2748 (1965)
Chatterjee, M.L., Roy, A.R.: Changes in the nor-adrenaline content of rabbit heart after treatment with ouabain. Bull. Calcutta Sch. Trop. Med. 17, 50–51 (1969)
Chen, G., Geiling, E.M.K.: Some aspects of biochemistry and pharmacology of heart. Schweiz. Med. Wochenschr. 77, 25–28 (1947)
Cherkes, A.I., Frantsuzova, S.B.: The influence of cardiac glycosides on the catecholamine content in the myocardium and adrenal glands in rats. Biull. Eksp. Biol. Med. 70, 49–52 (1970)
Chidsey, C.A.: Potential cellular defects responsible for myocardial failure. In: Factors influencing myocardial contractility. Tanz, R.D., Kavaler, F., Roberts, J. (eds.), pp. 3742. New York: Academic Press 1967
Clancy, R.L., Graham, T.P. Jr., Powell, W.J. Jr., Gilmore, J.P.: Inotropic augmentation of myocardial oxygen consumption. Am. J. Physiol. 212, 1055–1061 (1967)
Clausen, T.: The relationship between the transport of glucose and cations across the cell membrane in isolated tissues. I. Stimulation of glycogen deposition and inhibition of lactic acid production in diaphragm induced by ouabain. Biochim. Biophys. Acta (Amst.) 109, 164–171 (1965)
Coleman, H.N.: Role of acetylstrophanthidin in augmenting myocardial oxygen consumption. Circ. Res. 21, 487–495 (1967)
Constantin, L.L., Franzini-Armstrong, C., Podolsky, R.J.: Localization of calcium-accu-mulating structures in striated muscle fibers. Science 147, 158–160 (1965)
Coulson, R.L.: Energetics of isovolumic contractions of the isolated rabbit heart. J. Physiol. (Lond.) 260, 45–53 (1976)
Coulson, R.L., Rusy, B.F.: A system for assessing mechanical performance, heat production and oxygen utilization of isolated perfused whole hearts. Cardiovasc. Res. 7, 859–869 (1973)
Covell, J.W., Braunwald, E., Ross, J. Jr., Sonnenblick, E.H.: Studies on digitalis. XVI. Ef- fects on myocardial oxygen consumption. J. Clin. Invest. 45, 1535–1542 (1966)
Cowley, A.W., Scott, J.C., Spitzer, J.J.: Myocardial FFA metabolism during coronary in- fusion of norepinephrine in conscious dogs. Am. J. Physiol. 217, 511–517 (1969)
Crass, M.F. III, McCaskill, E.S., Shipp, J.C.: Effect of pressure development on glucose and palmitate metabolism in perfused heart. Am. J. Physiol. 216, 1569–1576 (1969)
Crass, M.F. III, McCaskill, E.S., Shipp, J.C., Murthy, V.K.: Metabolism of endogenous lipids in cardiac muscle: effect of pressure development. Am. J. Physiol. 220, 428–435 (1971)
Crass, M.F. III, Shipp, J.C.: Metabolism of exogenous and endogenous fatty acids in heart muscle. In: Myocardiology. Bajusz, E., Rona, G. (eds.), pp. 115–126. München, Berlin, Wien: Urban & Schwarzenberg 1972
Crevasse, L., Shipp, J.C.: The interactions of calcium and lanatoside C on carbohydrate metabolism in myocardial tissue slices. Mem. IV. Congr. Mund. Cardiol., Mexico City, 1962 vd 5, 208–215 (1962)
Crevasse, L., Wheat, M.W.: Role of calcium and lanatoside C in increasing oxygen con-sumption in human myocardial tissue slices. Circ. Res. 11, 721–726 (1962)
Dal Pra, P., Periti, P., Rossini, L.: Ouabain effect on the levels of nucleotide phosphates in frog heart perfusate. Pharmacol. Res. Commun. 4, 287–304 (1972)
Dal Pra, P., Segre, G.: Effect of ouabain on the kinetics of ATP hydrolysis in the guinea pig heart. Pharmacol. Res. Commun. 12, 73–84 (1980)
Danforth, W.H., Ballard, F.B., Kako, K., Choudhury, J.D., Bing, R.J.: Metabolism in heart failure. Circulation 21, 112–123 (1960)
Davies, R.E.: A molecular theory of muscle contraction: calcium-dependent contractions with hydrogen bond formation plus ATP-dependent extensions of part of the myosin-actin cross-bridges. Nature (Lond.) 199, 1068–1074 (1963)
Davis, E.J., The effects of insulin and adrenaline on the metabolism of glucose and lactate by perfused guinea pig hearts. Can. J. Biochem. 41, 1001–1010 (1965)
Delaunois, A.L., Bernard, P.J., Dujardin, J.P.: Influence of cardiotonic and cardioplegic agents on the heat production of the heart. Arch. Int. Physiol. Biochim. 82, 229–238 (1974)
DeMots, H., Rahimtoola, S.H., Kremkau, E.L., Bennett, W., Mahler, D.: Effects of ouabain on myocardial oxygen supply and demand in patients with chronic coronary artery disease. J. Clin. Invest. 58, 312–319 (1976)
DeMots, H., Rahimtoola, S.H., McAnulty, J.H., Porter, G.A.: Effects of ouabain on coronary and systemic vascular resistance and myocardial oxygen consumption in patients with heart failure. Am. J. Cardiol. 41, 88–93 (1978)
Dönges, C., Heitmann, M., Jungbluth, H., Meinertz, T., Schmelzle, B., Scholz, H.: Effectiveness of theophylline to increase cyclic AMP levels and force of contraction in electrically paced guinea-pig auricles. Comparison with isoprenaline, calcium, and ouabain. Naunyn-Schmiedebergs Arch. Pharmacol. 301, 87–97 (1977)
Döring, H.J., Hauf, G.: Kontraktilität sowie ATP- und Kreatinphosphat-Konzentrationen des Meerschweinchenmyokards bei Normoxie und verschiedenen Hypoxiegraden. Herz/Kreisl. 9, 926–933 (1977)
Doull, J., Herrmann, R.G., Geiling, E.M.K., Dubois, K.P.: Effects of Bufagin on the respiration of cardiac muscle and other tissues. Arch. Int. Pharmacodyn. 86, 487–496 (1951)
Ebashi, S.: Excitation — contraction coupling. Ann. Rev. Physiol. 38, 293–313 (1976)
Ebashi, S., Endo, M.: Calcium ion and muscle contraction. Prog. Biophys. Mol. Biol. 18, 123–183 (1968)
Ebashi, S., Lipmann, F.: Adenosine triphosphate-linked concentration of calcium ions in a particulate fraction of rabbit muscle. J. Cell. Biol. 14, 389–400 (1962)
Edman, K.A.P.: Action of ouabain on heart actomyosin. Acta Physiol. Scand. 21, 230–237(1950)
Edman, K.A.P.: Wirkung des Ouabains auf das Aktomyosin der Herzmuskulatur. Experientia (Basel) 7, 71–72 (1951)
Elbrink, J., Bihler, I.: Membrane transport: its relation to cellular and metabolic rates. Science 188, 1177–1184 (1975)
Endo, M.: Calcium release from the sarcoplasmic reticulum. Physiol. Rev. 57, 71–108 (1977)
Erbel, R.: Belastungs-EKG unter Digitalistherapie. Dtsch. Med. Wochenschr. 102, 1892 (1977)
Erbel, R.: Belastungs-EKG unter Therapie von herzwirksamen Glykosiden. Dtsch. Med. Wochenschr. 103, 632 (1978)
Fain, J.N., Jacobs, M.D., Clement-Cormier, Y.C.: Interrelationship of cyclic AMP, lipolysis, and respiration in brown fat cells. Am. J. Physiol. 224, 346–351 (1973)
Feinberg, H., Boyd, E., Tanzini, G.: Mechanical performance and oxygen utilization of the isovolumic rabbit heart. Am. J. Physiol. 215, 132–139 (1968)
Feinberg, H., Katz, L.N., Boyd, E.: Determinants of coronary flow and myocardial oxygen consumption. Am. J. Physiol. 202, 45–52 (1962)
Finkelstein, M., Bodansky, O.: The effect of cardiac glycosides on the respiration of cardiac muscle. J. Pharmacol. Exp. Ther. 94, 274–287 (1948)
Feinberg, H., Katz, L.N., Boyd, E.: Determinants of coronary flow and myocardial oxygen consumption. Am. J. Physiol. 202, 45–52 (1962)
Ford, L.E., Podolsky, R.J.: Regenerative calcium release within muscle cells. Science 167, 58–59 (1970)
Frantsuzova, S.B.: Action of cardiac glycosides on the concentrations of adenyl nucleotides and nicotinamide-adenine dinucleotides in the rat myocardium. Biull. Eksp. Biol. Med. 77, 527–529 (1974)
Fritz, P.J.: Cardiac glycoside effects on rat and guinea pig phospholipids. Res. Commun. Chem. Path. Pharmacol. 12, 741–749 (1975)
Furchgott, R.F., DeGubareff, T.: High-energy phosphate content of cardiac muscle under various experimental conditions which alter contractile strength. J. Pharmacol. Exp. Ther. 124, 203–218 (1958)
Furchgott, R.F., Lee, K.S.: High energy phosphate and the force of contraction of cardiac muscle. Circ. Res. 21, 416–432 (1961)
Garfield, R.E., Somlyo, A.V., Chacko, S., Somlyo, A.P.: Golgi-specific ultrastructural effects of the ionophore X537A in muscle. Fed. Proc. 33, 1459 (1974)
Genuit, H., Haarmann, W.: Zur Frage der Spezifität der Digitalisstoffwechselwirkung an Herz-und Skeletmuskulatur von Ratte und Meerschweinchen. Arch. Exp. Pathol. Pharmakol. 196, 481–492 (1940)
Gervais, A., Busch, U., Wood, J.M., Schwartz, A.: Effect of a toxic in vivo dose of ouabain on guinea-pig heart mitochondria. J. Mol. Cell. Cardiol. 10, 1003–1015 (1978)
Gibbs, C.L.: Cardiac energetics. Physiol. Rev. 58, 174–254 (1978)
Gibbs, C.L., Chapman, J.B.: Cardiac heat production. Ann. Rev. Physiol. 41, 507–519 (1979)
Gibbs, C.L., Gibson, W.R.: Effect of ouabain on the energy output of rabbit cardiac muscle. Circ. Res. 24, 951–967 (1969)
Gleason, W.L., Braunwald, E.: Studies on the first derivative of the ventricular pressure pulse in man. J. Clin. Invest. 41, 80–91 (1962)
Göksel, F., Katz, L.N., Feinberg, H.: Effect of ouabain on coronary flow, performance of the heart and its oxidative metabolism. Am. J. Physiol. 204, 21–27 (1963)
Gollwitzer-Meier, K., Krüger, E.: Herzenergetik und Strophanthinwirkung bei verschiede-nen Formen der experimentellen Herzinsuffizienz. Pflügers Arch. 238, 251–278 (1937)
Gonda, O., Quastel, J.H.: Effects of ouabain on cerebral metabolism and transport mech-anisms in vitro. Biochem. J. 84, 394–406 (1962)
Gousios, A.G., Felts, J.M., Havel, R.J.: Effects of ouabain on force of contraction, oxygen consumption, and metabolism of free fatty acids in the perfused rabbit heart. Circ. Res. 21, 445–448 (1967)
Greeff, K.: Zur Pharmakologie der herzwirksamen Glykoside. Klin. Physiol. 1, 340–370 (1963)
Gregg, D.E., Rayford, C.R., Khouri, E.M., Kattus, A.A., McKeever, W.P.: Effect of alteration of coronary perfusion pressure on oxygen uptake of left myocardium. Circulation 16, 888 (1957)
Greiner, T.: Relationship of force of contraction to high-energy phosphate in heart muscle. J. Pharmacol. Exp. Ther. 105, 178–195 (1952)
Gremels, H.: Zur Physiologie und Pharmakologie der Energetik des Säugetierherzens. Arch. Exp. Pathol. Pharmakol. 169, 689–724 (1933)
Gremels, H.: Über den Einfluß von Digitalisglykosiden auf die energetischen Vorgänge am Säugetierherzen. Arch. Exp. Pathol. Pharmakol. 186, 625–660 (1937)
Grisolia, S.: The potentiating effect of digitoxin and quinidine on dinitrophenol uncoupling of oxidative phosphorylation. Biochim. Biophys. Acta (Amst.) 18, 437–438 (1955a)
Grisolia, S.: Digitoxin and uncoupling of oxidative phosphorylation. Circulation 12, 716 (1955b)
Gross, G.J., Warltier, D.C., Hardman, H.F., Somani, P.: The effect of ouabain on nutrition- al circulation and regional myocardial blood flow. Am. Heart J. 93, 487–495 (1977)
Gruhzit, C.C., Farah, A.E.: A comparison of the positive inotropic effects of ouabain and epinephrine in heart failure induced in the dog heart-lung preparation by sodium pentobarbital, dinitrophenol, sodium cyanide, and sodium azide. J. Pharmacol. Exp. Ther. 114, 334–342 (1955)
Guerra, F., Eberstadt, P.L., Veerkamp, A.: Acción de la uabaina sobre la liberación enzimâtica de fosforo en el sistema miosina trifosfato de adenosina. Arch. Inst. Cardiol. Méx. 16, 449–455 (1946)
Günther, T., Winkelmann, W.: Einfluß von Steroidhormonen auf den aktiven Transport von Glykokoll in Vogelerythrocyten. Naunyn-Schmiedebergs Arch. Pharmacol. 242, 277–283 (1961)
Güttler, K.: Untersuchungen zum myokardialen Stoff-und Energiewechsel. Wärmeproduktion und Sauerstoffverbrauch schlagender und insbesondere K+-stillgestellter Herzen unter dem Einfluß von Ca++, Adrenalin und Strophanthin. Dissertation, Pharmakologisches Institut, Hannover (1974)
Güttler, K., Klaus, W., Landgraf, W.: Influence of ouabain and hypoxia on the ECG of the isolated guinea pig heart. Naunyn-Schmiedebergs Arch. Pharmacol. 311(suppl.), R 41 (1980)
Güttler, K., Theisohn, M.: Oxygen consumption and heat production of K+-arrested hearts under the influence of Ca ++, ouabain and adrenaline Naunyn-Schmiedebergs Arch. Pharmacol. 277(suppl.), R24 (1973)
Gutman, M., Kearney, E.B., Singer, T.P.: Multiple control mechanisms for succinate dehy- drogenase in mitochondria. Biochem. Biophys. Res. Commun. 44, 526–532 (1971)
Hafkenschiel, J.H., Cerletti, A.: Effects of acetyldigitoxin, a new cardiac glycoside, on work performance and 02-consumption of the canine heart—lung preparation. J. Pharmacol. Exp. Ther. 110, 23 (1954)
Hajdu, S., Weiss, H., Titus, E.: The isolation of a cardiac active principle from mammalian tissue. J. Pharmacol. Exp. Ther. 120, 99–113 (1957)
Harvey, S.C.: Radiophosphorus metabolism of guinea pig hearts and actions of digitoxin and pentobarbital. Am. J. Physiol. 183, 559–564 (1955)
Hasselbach, W., Makinose, M.: Die Calciumpumpe der äErschlaffungsgrana“ des Muskels und ihre Abhängigkeit von der ATP-Spaltung. Biochem. Z. 333, 518–528 (1961)
Hajdu, S., Weiss, H., Titus, E.: The isolation of a cardiac active principle from mammalian tissue. J. Pharmacol. Exp. Ther. 120, 99–113 (1957)
Heeg, E.: Untersuchungen über den Einfluß herzwirksamer Pharmaka auf den Druckablauf in der linken Herzkammer der Katze. Habil.-Schrift. Düsseldorf (1966)
Hegglin, R., Grauer, H., Münchinger, R.: Die Beeinflussung der Adenosintriphosphatase-aktivität des Herzmuskels durch verschiedene Substanzen. Experientia (Basel) 5, 127 (1949)
Heimreich, E.: Der Einfluß von Strophanthin auf das Zytochromo-oxydase-Zytochrom-CSystem. Biochem. Z. 321, 144–151 (1950)
Helmreich, E., Simon, K.: Zur Frage der Wirkung von Digitalisstoffen auf das Aktomyosin und die Adenosintriphosphatase des Herzmuskels. Z. Naturforsch. 7b, 341–350 (1952)
Herrmann, R.G.: Studies on the effect of ouabain on cardiac muscle respiration. Arch. Int. Pharmacodyn. 81, 235–241 (1950)
Herrmann, R.G., Flamboe, G.E., Chen, K.K.: The effect of nine cardiac steroids and epinephrine on the respiration of heart muscle slices. J. Pharmacol. Exp. Ther. 112, 23–28 (1954)
Ho, R.J., Jeanrenaud, B., Renold, A.E.: Ouabain-sensitive fatty acid release from isolated fat cells. Experientia (Basel) 22, 86–87 (1966)
Ho, R.J., Jeanrenaud, B.: Insulin-like action of ouabain. I. Effect on carbohydrate metabolism. Biochim. Biophys. Acta (Amst.) 144, 61–73 (1967)
Ho, R.J., Jeanrenaud, B., Posternak, T.H., Renold, A.E.: Insulin-like action of ouabain. II. Primary antilipolytic effect through inhibition of adenyl cyclase. Biochim. Biophys. Acta (Amst.) 144, 74–82 (1967)
Hochrein, H., Lehmann, H.-U., Helwing, H.-P.: EKG-Veränderungen bei Koronarinsuffi-zienz und unter dem Einfluß von Digitalis. Klinikarzt 4, 403–407 (1975)
Hoeschen, R.J.: The effect of ouabain on substrate metabolism in the isolated perfused rat heart. Clin. Res. 17, 636 (1969)
Hoeschen, R.J.: The effect of ouabain on substrate metabolism in the isolated perfused rat heart. Can. J. Physiol. Pharmacol. 49, 412–419 (1971)
Hokin, L.E., Hokin, M.R.: Evidence for phosphatidic acid as the sodium carrier. Nature (Lond.) 184, 1068–1069 (1959)
Hokin, L.E., Hokin, M.R.: Diglyceride kinase and phosphatidic acid phosphatase in erythrocyte membranes. Nature (Lond.) 189, 836–837 (1961)
Holloszy, J.O., Narahara, H.T.: Enhanced permeability to sugar associated with muscle contraction. J. Gen. Physiol. 50, 551–562 (1967)
Hood, W.B. Jr., Letac, B., Roberge, G., Lown, B.: Direct digitalization of the myocardium. Hemodynamic effects. Am. J. Cardiol. 22, 667–671 (1968)
Jacobson, A.L.: Effect of ouabain on the ATPase of cardiac myosin B at high ionic strength. Circ. Res. 22, 625–632 (1968)
Jenden, D.J., Fairhurst, A.S.: The pharmacology of ryanodine. Pharmacol. Rev. 21, 1–26 (1969)
Jesmok, G.J., Calvert, D.N., Lech, J.J.: The effect of inotropic agents on glycerol release and protein kinase activity ratios in the isolated perfused rat heart. J. Pharmacol. Exp. Ther. 200, 187–194 (1977)
Jesmok, G.J., Lech, J.J., Calvert, D.N.: The effects of epinephrine, glucagon, and ouabain on glycerol release in the isolated perfused rat heart. Pharmacologist 17, 218 (1975)
Kahler, R.L., Braunwald, E., Kelminson, L.L., Kedes, L., Chidsey, C.A., Segal, S.: Effect of alterations of coronary blood flow on the oxygen consumption of the non-working heart. Circ. Res. 13, 501–509 (1963)
Kassebaum, D.G., Griswold, H.E.: Digitalis in nonfailing cardiac diseases. Prog. Cardiovasc. Dis. 12, 484–492 (1970)
Kedem, J., Levinger, I.M., Baum, M., Rogel, S.: Heart rate and myocardial substrate preference during normal and hypoxic perfusion of the heart in vivo. Arch. Int. Physiol. Biochim. 83, 53–62 (1975)
Kien, G.A., Gomoll, A.W., Sherrod, T.R.: Action of digoxin and insulin on transport of glucose through myocardial cell membrane. Proc. Soc. Exp. Biol. Med. 103, 682–685 (1960)
Kien, G.A., Sherrod, T.R.: The effect of digoxin on the intermediary metabolism of the heart as measured by glucose-C14 utilization in the intact dog. Circ. Res. 8, 188–198 (1960)
Kim, N.D., Bailey, L.E., Dresel, P.E.: The effect of insulin on the subcellular distribution and the inotropic effect of 3H-digoxin in the guinea pig heart. Life Sci. 9, 1135–1139 (1970)
Kim, N.D., Dresel, P.E.: The effect of insulin on the subcellular distribution and the inotropic effect of 3H-digoxin in the guinea pig heart. Fed. Proc. 29, 352 (1970)
Kimura, T.E., Dubois, K.P.: Inhibition of enzymatic hydrolysis of ATP by certain cardiac drugs. Science 106, 370–371 (1947)
Kini, P.M., Willems, J.L., Batchlor, C., Pipberger, H.V.: ST-T changes induced by digitalis and ventricular hypertrophy: differentiation by quantitative analysis. J. Electrocardiol. 5, 101–110 (1972)
Kjekshus, J.K., Maroko, P.R., Sobel, B.E.: Distribution of myocardial injury and its relation to epicardial ST-segment changes after coronary artery occlusion in the dog. Cardiovasc. Res. 6, 490–499 (1972)
Klaus, W.: Neuere Aspekte über den Wirkungsmechanismus der Herzglykoside. Z. Grundlagenforsch. 2, 43–117 (1964)
Klaus, W., Güttler, K., Theisohn, M., Theisohn-Schwedhelm, I.: The relationship between mechanical function and heat production in isolated hearts under the influence of ouabain and epinephrine. 5th. Int. Congress on Pharmacology, San Francisco, Calif. USA, Abstr. 755, p. 126, 1972
Klaus, W., Krebs, R.: Über den Einfluß von Digitoxigenin and Strophanthin auf mechanische Aktivität and Sauerstoffverbrauch isolierter Herzmuskelpräparate. NaunynSchmiedebergs Arch. Pharmacol. 261, 102–117 (1968)
Klaus, W., Krebs, R.: Über die Abhängigkeit der Strophanthinwirkung auf den myokardialen Sauerstoffverbrauch vom Funktionszustand des Herzens. Naunyn-Schmiedebergs Arch. Pharmacol. 264, 337–353 (1969)
Klein, W.W., Brandt, D., Pavek, P.: Effekt von K-Strophanthin auf Hämodynamik und Stoffwechsel des koronarkranken Herzens in Ruhe und während frequenzinduzierter Angina pectoris. Verh. Dtsch. Ges. Inn. Med. 83, 1646–1650 (1977)
Koch-Weser, J., Berlin, C.M. Jr., Blinks, J.R.: Effects of acetylstrophanthidin, levarterenol, and carbachol on the interval-strength relationship of heart. In: Proceedings of 2 nd International Pharmacological Meeting, Prague, 1963, Vol. 5, pp. 63–72. Oxford: Perga-mon Press 1964
Kötter, V., Schüren, K.-P., Schröder, R.: Der Einfluß von Digoxin auf Coronardurchblutung und myocardialen 02-Verbrauch bei Patienten mit Angina pectoris. Verh. Dtsch. Ges. Inn. Med. 83, 1644–1647 (1977)
Korth, C., Spang, K.: Die Wirkung des Digitoxins auf Elektrokardiogramm und Herzmus-kel der Katze. Naunyn-Schmiedebergs Arch. Pharmacol. 184, 349–364 (1937)
Kostyo, J.L., Schmidt, J.E.: Inhibitory effects of cardiac glycosides and adrenal steroids on amino acid transport. Am. J. Physiol. 204, 1031–1038 (1963)
Koyama, T., Brecht, K., Koyama, Y.: Wirkungen von Strophanthin und Ca’ auf den 02-Verbrauch und die Mechanik (Zuckung und Tonus) von Papillarmuskeln des Meerschweinchens. Z. Kreisl. Forsch. 55, 838–845 (1966)
Kraupp, O., Raberger, G., Chirikdjian, J.J.: The effects of alpha-acetyldigoxin on cardiac dynamics and myocardial glucose and free fatty acid extraction in nonfailing dogs. Pharmacology 1, 345–357 (1968)
Krebs, H.A.: Body size and tissue respiration. Biochim. Biophys. Acta (Amst.) 4, 249–269 (1950)
Krebs, R.: Über die unterschiedliche Wirkung von Calcium und Noradrenalin auf den Sauerstoffverbrauch isolierter Meerschweinchenvorhöfe. Pflügers Arch. 315, 110–124 (1970)
Krebs, R., Klaus, W.: Über die Beziehung zwischen Sauerstoffverbrauch und Kontraktions-kraft isolierter Meerschweinchenvorhöfe unter dem Einfluß von Digitoxin. NaunynSchmiedebergs Arch. Pharmacol. 255, 30 (1966)
Kreisberg, R.A., Williamson, J.R.: Metabolic effects of ouabain in the perfused rat heart. Am. J. Physiol. 207, 347–351 (1964)
Kühn, P., Brachfeld, N.: Zur Wertigkeit des Tension-Time-Index und der maximalen linksventrikulären Druckanstiegsgeschwindigkeit (dp/dt) in der Korrelation zum myokardialen Sauerstoffverbrauch. Z. Kreisl. Forsch. 58, 244–251 (1969)
Kujalova, V., Mosinger, B.: Cold-and ouabain-sensitive uptake of glucose stimulated by insulin in incubated rat adipose tissue. Biochim. Biophys. Acta (Amst.) 127, 255–257 (1966)
Kuschinsky, G., Lange, G., Turba, F.: Über die Wirkung von Digitoxin auf die Freilegung von Actomyosin und seinen Komponenten aus den Strukturen des Muskels. NaunynSchmiedebergs Arch. Pharmacol. 215, 259–269 (1952)
Kutschera-Aichberger, H.: Über Herzschwäche. Wien. Arch. Inn. Med. 18, 209–358 (1929)
Kypson, J., Hait, G.: The effects of ouabain, calcium, and potassium on the transport and incorporation of some amino acids into rabbit atrial tissue in vitro. J. Pharmacol. Exp. Ther. 177, 398–408 (1971)
Langemann, H.: Über den Einfluß von herzaktiven Glukosiden auf die Adenosintriphosphatase aus Herzmuskelzellfraktionen. Helv. Physiol. Pharmacol. Acta 11, C 20–21 (1953)
Langemann, H., Brody, T.M., Bain, J.A.: In vitro effects of ouabain on slices and mitochon-drial preparations from heart and brain. J. Pharmacol. Exp. Ther. 108, 274–280 (1953)
Langer, G.A.: Heart: excitation-contraction coupling. Ann. Rev. Physiol. 35, 55–86 (1973)
Lee, K.S.: A new technique for the simultaneous recording of oxygen consumption and con-traction of muscle: The effect of ouabain on cat papillary muscle. J. Pharmacol. Exp. Ther. 109, 304–312 (1953)
Lee, K.S.: Sensitive method for simultaneous recording contractility and respiration of heart muscle. Fed. Proc. 17, 387 (1958)
Lee, K.S.: The relationship of the oxygen consumption to the contraction of the cat papillary muscle. J. Physiol. (Lond.) 151, 186–201 (1960)
Lee, K.S., Klaus, W.: The subcellular basis for the mechanism of inotropic action of cardiac glycosides. Pharmacol. Rev. 23, 193–261 (1971)
Lee, K.S., McElroy, W.D.: Effect of ouabain on mitochondria. Fed. Proc. 14, 362 (1955)
Lee, K.S., Schwartz, A., Burstein, R.: An effect of cardiac glycosides on oxidative phosphor-ylation by heart mitochondria. J. Pharmacol. Exp. Ther. 129, 123–127 (1960a)
Lee, K.S., Shin, B.C.: Studies on the active transport of Ca + + in human red cells. J. Gen. Physiol. 54, 713–729 (1969)
Lee, K.S., Yu, D.H., Burstein, R.: The effect of ouabain on the oxygen consumption, the high energy phosphates and the contractility of the cat papillary muscle. J. Pharmacol. Exp. Ther. 129, 115–122 (1960b)
Lee, K.S., Yu, D.H., Lee, D.I., Burstein, R.: The influence of potassium and calcium on the effect of ouabain on cat papillary muscle. J. Pharmacol. Exp. Ther. 132, 139–148 (1961)
Lehmann, H.-U., Hochrein, H.: Digitalishaftzeichen im Elektrokardiogramm. Dtsch. Med. Wochenschr. 103, 315–316 (1978)
Lehmann, H.-U., Janitzki, S., Hochrein, H.: Zur Deutung von Digitalishaftzeichen im Elektrokardiogramm. Dtsch. Med. Wochenschr. 102, 1335–1341 (1977)
Lehmann, H.-U., Witt, E., Hochrein, H.: Zunahme von Angina pectoris and ST-StreckenSenkung im EKG durch Digitalis. Z. Kardiol. 67, 57–66 (1978)
Lehmann, H.-U., Witt, E., Hochrein, H.: Wirkung von Nitroglycerin auf digitalisinduzierte ST-Streckensenkungen bei koronarkranken Patienten. Dtsch. Med. Wochenschr. 104, 501–506 (1979)
Lehninger, A.L.: Biochemie, pp.341–361. 2nd. ed. Weinheim, New York: Verlag Chemie 1977
Lehninger, A.L., Carafoli, E., Rossi, C.S.: Energy-linked ion movements in mitochondrial systems. Adv. Enzymol. 29, 259–320 (1967)
Leonard, C., Hajdu, S.: The effects of potassium on the inotropic action of cardiac glycosides. Clin. Res. 7, 19–20 (1959)
Levine, H.J., Wagman, R.J.: Energetics of the human heart. Am. J. Cardiol. 9, 372–383 (1962)
Lindower, J.O., Marks, B.H.: Ultrastructural changes in guinea-pig myocardium after acute ouabain treatment. J. Pharmacol. Exp. Ther. 202, 76–88 (1977)
Lowry, O.H., Passonneau, J.V.: Kinetic evidence for multiple binding sites on phosphofructokinase. J. Biol. Chem. 241, 2268–2279 (1966)
Marchetti, G.V., Aguggini, G., Merlo, L., Noseda, V., Santi, A.: Coronary blood flow, oxygen consumption of the myocardium and cardiac work in the sheep. Pflügers Arch. 290, 80–88 (1966)
Marinetti, G.V., Temple, K., Stotz, E.: The in vivo effect of digitoxin on rat heart phosphatides. J. Lipid Res. 2, 188–190 (1961)
Maroko, P.R., Braunwald, E., Covell, J.W.: The effect of digitalis on the severity of myocardial ischemic injury following experimental coronary occlusion. Pharmacologist 12, 212 (1970)
Mason, D.T., Braunwald, E.: Studies on digitalis. IX. Effects of ouabain on the non-failing human heart. J. Clin. Invest. 42, 1105–1111 (1963)
Mayer, S.E.: The effect of catecholamines on cardiac metabolism. Circ. Res. 34 and 35 (suppl. III), 129–135 (1974)
Mayer, S.E., Moran, N.C.: Relation between pharmacologic augmentation of cardiac contractile force and the activation of myocardial phosphorylase. J. Pharmacol. Exp. Ther. 129, 271–281 (1960)
McDonald, R.H. Jr.: Developed tension: a major determinant of myocardial oxygen consumption. Am. J. Physiol. 210, 351–356 (1966)
McDonald, R.H. Jr.: Myocardial heat production: its relationship to tension development. Am. J. Physiol. 220, 894–900 (1971)
Messer, J.V., Neill, W.A.: Oxygen supply of the human heart. Am. J. Cardiol. 9, 384–394 (1962)
Moe, G.K., Farah, A.E.: Digitalis and allied cardiac glycosides. In: The pharmacological basis of therapeutics. Goodman, L.S., Gilman, A. (eds.), pp. 653–682. 5th. ed. New York: Macmillan Publ. 1975
Monroe, R.G., French, G.N.: Left ventricular pressure-volume relationships and myocar-dial oxygen consumption in the isolated heart. Circ. Res. 9, 362–374 (1961)
Mor, M.A.: ATPase activity of myofibrils and granules isolated from muscle. Experientia (Basel) 9, 342–343 (1953)
Mor, M.A.: The influence of progesterone on adenosintriphosphatase. Experientia (Basel) 11, 33–35 (1955)
Morgan, H.E., Neely, J.R., Brineaux, J.P., Park, C.R.: Regulation of glucose transport. In: Control of energy metabolism. Chance, B., Estabrook, R.W., Williamson, J.R. (eds.), pp 347–355. New York: Academic Press 1965
Morgenstern, C., Holjes, U., Arnold, G., Lochner, W.: The influence of coronary pressure and coronary flow on intracoronary blood volume and geometry of the left ventricle. Pflügers Arch. 340, 101–111 (1973)
Morkin, E., LaRaia, P.J.: Biochemical studies on the regulation of myocardial contractility. New Engl. J. Med. 290, 445–451 (1974)
Müller, E.R.: Uber die aerobe and anaerobe Stoffwechselkapazität des isolierten Warmblüterherzens. Pflügers Arch. 276, 42–55 (1962)
Müller-Ruchholtz, E.R.: Über die Leistungsfähigkeit des anoxydativen Herzstoffwechsels. Basic Res. Cardiol. 68, 480–508 (1973)
Münchinger, R.: Untersuchungen über die Aktivität der Adenosintriphosphatase im Herzmuskel, als Beitrag zur Pathogenese der sog. energetisch-dynamischen Herzinsuffizienz. Cardiologia (Basel) 22, 145–168 (1953)
Nayler, W.G.: Effect of strophanthin G on oxidative metabolism in cardiac muscle. Nature (Lond.) 188, 70–71 (1960)
Neely, J.R., Liebermeister, H., Battersby, E.J., Morgan, H.E.: Effect of pressure develop-ment on oxygen consumption by isolated heart. Am. J. Physiol. 212, 804–814 (1967a)
Nayler, W.G.: Effect of strophanthin G on oxidative metabolism in cardiac muscle. Nature (Lond.) 188, 70–71 (1960)
Neely, J.R., Liebermeister, H., Morgan, H.E.: Effect of pressure development on membrane transport of glucose in isolated rat heart. Am. J. Physiol. 212, 815–822 (1967b)
Neely, J.R., Morgan, H.E.: Relationship between carbohydrate and lipid metabolism and the energy balance of heart muscle. Ann. Rev. Physiol. 36, 413–459 (1974)
Neely, J.R., Rovetto, M.J., Oram, J.F.: Myocardial utilization of carbohydrate and lipids. Progr. Cardiovasc. Dis. 15, 289–329 (1972)
Neely, J.R., Whitmer, K.M., Mochizuki, S.: Effects of mechanical activity and hormones on myocardial glucose and fatty acid utilization. Circ. Res. 38(suppl. I), 22–30 (1976)
Nelson, D.R., Cornatzer, W.E.: Effect of digoxin, aldosterone, and dietary sodium chloride on the incorporation of inorganic P32 into liver and kidney nuclear and mitochondrial phospholipids. Proc. Soc. Exp. Biol. Med. 116, 237–242 (1964)
Nicholls, D., Kanfer, J., Titus, E.: The effect of ouabain on the incorporation of inorganic P-32 into phospholipid. J. Biol. Chem. 237, 1043–1049 (1962)
Nowy, H., Helmreich, E.: Der Einfluß von Strophanthin auf die Gewebeatmung verschie-dener Abschnitte des Rattenherzens. Klin. Wochenschr. 28, 686–687 (1950)
Ochs, H.R., Otten, H., Bodem, G.: Digoxin-induzierte Veränderungen des Belastungs-EKG in Relation zur Digoxinplasmakonzentration. Klin. Wochenschr. 57, 161–168 (1979)
Ogilvie, R.I., Klassen, G.A.: Metabolic effect and uptake of [3H] digoxin in the forearm of man. Clin. Sci. 42, 567–577 (1972)
Olson, R.E., Barnhorst, D.A.: The control of energy production and utilization in cardiac muscle. In: Recent. Advanc. Stud. cardiac. Struct. Metab. (Vol. 3) Myocardial metabolism. Dhalla, N.S. (ed.), pp. 11–30. München, Berlin, Wien: Urban & Schwarzenberg 1974
Olson, R.E., Dhalla, N.S., Sun, C.N.: Changes in energy stores in the hypoxic heart. Cardiology 56, 114–124 (1971/1972)
Olson, R.E., Piatnek, D.A.: Conservation of energy in cardiac muscle. Ann. N.Y. Acad. Sci. 72, 466–478 (1959)
Opie, L.H.: Coronary flow rate and perfusion pressure as determinants of mechanical function and oxidative metabolism of isolated perfused rat heart. J. Physiol. (Lond.) 180, 529–541 (1965)
Opie, L.H.: Metabolism of the heart in health and disease. I. Am. Heart J. 76, 685–698 (1968)
Opie, L.H.: Metabolism of the heart in health and disease II Am. Heart J. 77, 100–122 (1969a)
Opie, L.H.: Metabolism of the heart in health and disease. III. Am. Heart J. 77, 383–410 (1969b)
Opie, L.H.: Substrate utilization and glycolysis in the heart. Cardiology 56, 2–21 (1971/ 1972 )
Opie, L.H., Shipp, J.C., Evans, J.R., Leboeuf, B.: Metabolism of glucose-U-C14 in perfused rat heart. Am. J. Physiol. 203, 839–843 (1962)
Page, R.G., Foltz, E.L., Sheldon, W.F., Wendel, H.: Effect of ouabain on coronary circulation and other circulatory functions in intact anesthetized dogs. J. Pharmacol. Exp. Ther. 101, 112–118 (1951)
Paine, C.M., Heinz, E.: The structural specificity of the glycine transport system of Ehrlich carcinoma cells. J. Biol. Chem. 235, 1080–1085 (1960)
Park, C.R., Crofford, O.B., Kono, T.: Mediated (non-active) transport of glucose in mammalian cells and its regulation. J. Gen. Physiol. 52, 296s-318s (1968)
Pelkonen, K.H.O.: Enzyme activities of myocardial energy metabolism during prolonged digoxin treatment in rats. Acta Pharmacol. Toxicol. 42, 1–6 (1978)
Pelosi, G., Conti, F., Agliati, G.: The effect of hypoxia on cardiac tissue (I) High energy phosphates content and oxygen uptake. Eur. J. Pharmacol. 8, 19–24 (1969)
Peters, H., Visscher, M.B.: Energy metabolism of the heart in failure and influence of drugs upon it. Am. Heart J. 11, 273–291 (1936)
Plaut, K.A., Gertler, M.M., Plaut, G.W.E.: Efficiency of oxidative phosphorylation of heart muscle mitochondria from digitalized guinea pigs. Circ. Res. 5, 226–229 (1957)
Posner, B.I., Fanburg, B.L.: Ribonucleic acid synthesis in experimental cardiac hypertrophy in rats. II. Aspects of regulation. Circ. Res. 23, 137–145 (1968)
Proctor, C.D., Mueller, G.S.: Digoxin effect on heart ATPase. Fed. Proc. 16, 328 (1957)
Raberger, G., Kraupp, O.: Herzdynamik und Herzstoffwechsel nach i.v. Verabreichung von alpha-Acetyldigoxin am Hund. Arch. Pharmakol. Exp. Pathol. 263, 246–247 (1969)
Read, W.D., Kelsey, F.E.: Effect of digoxin on myokinase activity. Science 125, 120–121 (1957)
Rebar, J. Jr., Rebar, B.T., Omachi, A.: Influence of digitoxin on labile and inorganic phosphates, lactate, glycogen, potassium, and sodium in dog ventricle. Circ. Res. 5, 504–509 (1957)
Reiter, M.: Wirkung von Strophanthin auf Kontraktionskraft und Sauerstoffverbrauch des Herzstreifens der Ratte. Arch. Exp. Pathol. Pharmakol. 219, 315–332 (1953)
Reiter, M., Barron, E.S.G.: Über die direkte Fermentwirkung von Herzglykosiden. Arch. Exp. Pathol. Pharmakol. 214, 341–348 (1952)
Reuter, H.: Divalent cations as charge carriers in excitable membranes. Prog. Biophys. Molec. Biol. 26, 1–43 (1973)
Risler, T., Grabensee, B., Grosse-Brockhoff, F.: EKG-Veränderungen und Digoxin-Serumkonzentration bei Digitalisintoxikationen. Dtsch. Med. Wochenschr. 100, 821–825 (1975)
Rollett, E.L., Yurchak, P.M., Hood, W.B., Gorlin, R.: Pressure-volume correlates of left ventricular oxygen consumption in the hypervolemic dog. Circ. Res. 17, 499–518 (1965)
Ross, J. Jr., Sonnenblick, E.H., Kaiser, G.A., Frommer, P.L., Braunwald, E.: Electroaugmentation of left ventricular performance and oxygen consumption by repetitive application of paired electrical stimuli. Circ. Res. 16, 332–342 (1965)
Rothlin, E., Bircher, R.: Pharmakodynamische Grundlagen der Therapie mit herzwirksamen Glykosiden. Ergebn. Inn. Med. Kinderheilk. 5, 457–552 (1954)
Rothlin, E., Schoelly, D.: Einfluß herzwirksamer Glykoside auf die Atmung des Herzens ge-messen mit der Warburg-Apparatur. Helv. Physiol. Acta 8, C 69–70 (1950)
Rothlin, E., Taeschler, M., Cerletti, A.: Action of dinitrophenol and lanatoside C on the ca-nine heart-lung preparation. Circ. Res. 3, 32–38 (1955)
Rothlin, E., Taeschler, M.: Zur Wirkung der herzwirksamen Glykoside auf den Myokardstoffwechsel. Fortschr. Kardiol. 1, 189–239 (1956)
Roy, A.R., Chatterjee, M.L.: Effect of ouabain on the catecholamine content of heart and adrenal gland of rabbits. Life Sci. 9, 395–401 (1970)
Rusy, B.F., Coulson, R.D.: Energy consumption in the isolated rabbit heart. Anesthesiology 39, 428–434 (1973)
Salomon, K., Riesser, O.: Zur Frage des Einflusses von Digitoxin und Strophanthin auf oxydative Vorgänge in Versuchen am Modell sowie am atmenden überlebenden Herzmuskelgewebe. Arch. Exp. Pathol. Pharmakol. 177, 450–462 (1935)
Sarnoff, S.J., Gilmore, J.P., Wallace, A.G., Skinner, N.S. Jr., Mitchel, J.H., Daggett, W.M.: Effect of acetylstrophanthidin therapy on cardiac dynamics, oxygen consumption and efficiency in the isolated heart with and without hypoxia. Am. J. Med. 37, 3–13 (1964)
Saunders, P.R., Webb, J.L., Thienes, C.H.: Metabolism of the heart in relation to drug action. V. Action of various drugs and other substances on some dehydrogenase systems of the heart. Arch. Int. Pharmacodyn. 81, 485–492 (1950)
Schaper, W.K.A., Lewi, R., Jageneau, A.H.M.: The determinants of the rate of change of left ventricular pressure (dp/dt). Arch. Kreisl. Forsch. 46, 27–41 (1965)
Schatzmann, H.J., Vincenzi, F.F.: Calcium movements across the membrane of human red cells. J. Physiol. (Lond.) 201, 369–395 (1969)
Schwartz, A.: Effect of a toxic dose of ouabain on guinea pig heart mitochondria. Fed. Proc. 34, 793 (1975)
Schwartz, A., Lindenmayer, G.E., Allen, J.C.: The Na+, K+-ATPase membrane transport system: importance in cellular function. In: Current topics in membranes and transport. Bronner, F., Kleinzeller, A. (eds.), Vol. 3, pp. 1–82. New York: Academic Press 1972
Schwartz, A., Lindenmayer, G.E., Allen, J.C.: The sodium-potassium-adenosinetriphosphatase: pharmacological, physiological, and biochemical aspects. Pharmacol. Rev. 27, 3–134 (1975)
Schwiegk, H., Jahrmärker, H.: Therapie der Herzinsuffizienz. Glykosidwirkungen auf das EKG. In: Handbuch der inneren Medizin, Band IX/1: Herz und Kreislauf. v. Bergmann, G., Frey, W., Schwiegk, H. (eds), pp. 500–504, 4. th. ed. Berlin, Göttingen, Heidelberg: Springer 1960
Scott, J.C., Finkelstein, L.J., Spitzer, J.J.: Myocardial removal of free fatty acids under normal and pathological conditions. Am. J. Physiol. 203, 482–486 (1962)
Segre, G.: Ricerche sul meccanismo d’azione de digitalici; effetti metabolici della uabaina. Arch. Int. Pharmacodyn. 80, 336–346 (1949)
Segre, G.: Sull’azione dei digitalici su alcuni enzimi. Boll. Sco. Ital. Biol. Sper. 26, 939 (1950)
Selzer, A., Malmborg, R.O.: Hemodynamic effects of digoxin in latent cardiac failure. Circulation 25, 695–702 (1962)
Severson, D.L.: Regulation of lipid metabolism in adipose tissue and heart. Can. J. Physiol. Pharmacol. 57, 924–937 (1979)
Shipp, J.C., Opie, L.H., Challoner, D.R.: Fatty acid and glucose metabolism in the perfused heart. Nature (Lond.) 189, 1018–1019 (1961)
Shipp, J.C., Thomas, J.M., Crevasse, L.: Oxidation of carbon-14-labelled endogenous lipids by isolated perfused rat heart. Science 143, 371–373 (1964)
Siedek, H., Hammerl, H., Kränzl, C., Pichler, O., Studlar, M.: Untersuchungen über die Stoffwechseleffekte eines parenteral verabreichten Herzglykosides. Wien. Klin. Wochenschr. 80, 585–586 (1968a)
Siedek, H., Hammerl, H., Kränzl, C., Pichler, O., Studlar, M.: Zum Einfluß der Herzglyko-side auf den Fettstoffwechsel. Verh. Dtsch. Ges. Kreislaufforsch. 34, 198–201 (1968b)
Siegel, J.H., Sonnenblick, E.H.: Isometric time-tension relationship as an index of myocar-dial contractility. Circ. Res. 12, 597–610 (1963)
Siess, M. Die Bedeutung des Substrates für den Sauerstoffverbrauch isolierter Meerschweinchenvorhöfe nach Leistungssteigerung durch g-Strophanthin oder Adrenalin. Arch. Exp. Pathol. Pharmakol. 261, 212–213 (1968)
Simaan, J., Fawaz, G., Jarawan, S.: The effect of ouabain-induced contractility on myocardial oxygen consumption. Naunyn-Schmiedebergs Arch. Pharmacol. 271, 249–261 (1971)
Skelton, C.L., Seagren, S.C., Poól, P.E.: Influence of digoxin on myocardial energy utilization. Circulation 42(suppl. III), 111 (1970)
Smith, J.A., Glassman, M., Lind, A.H., Post, M., Sohn, H., Warren, S.: Effects of ouabain on beat and oxygen consumption of embryonic chick hearts. Proc. Soc. Exp. Biol. Med. 86, 747–749 (1954)
Smith, J.A., Post, M.: Effect of k-Strophanthoside on oxygen consumption of embryonic chick hearts as measured in cartesian driver. Am. J. Physiol. 163, 751 (1950)
Snow, T.R.: The role of Ca -I- + in determining the relation between metabolism and mechan-ical performance in rabbit papillary muscle. Fed. Proc. 38, 1048 (1979)
Sonnenblick, E.H., Ross, J. Jr., Covell, J.W., Kaiser, G.A., Braunwald, E.: Velocity of contraction as a determinant of myocardial oxygen consumption. Am. J. Physiol. 209, 919927 (1965)
Sonnenblick, E.H., Ross, J. Jr., Braunwald, E.: Oxygen consumption of the heart. Newer concepts of its multifactoral determination. Am. J. Cardiol. 22, 328–336 (1968)
Sonnenblick, E.H., Williams, J.F. Jr., Glick, G., Mason, D.T., Braunwald, E.: Studies on digitalis. XV. Effects of cardiac glycosides on myocardial force-velocity relations in the nonfailing human heart. Circulation 34, 532–539 (1966)
Spitzer, J.J.: Effect of lactate infusion on canine myocardial free fatty acid metabolism in vivo. Am. J. Physiol. 226, 213–217 (1974)
Staub, H.: Zum Wirkungsmechanismus der Herzglykoside. Dtsch. Med. Wochenschr. 82, 5–13 (1957)
Staub, H.: Pharmacology of cardiac glycoside. Am. J. Cardiol. 3, 776–793 (1959)
Strauer, B.E., Tauchert, M., Kochsiek, K.: Coronary flow, coronary vascular reserve and oxygen consumption in patients with and without chronic cardiac failure. In: Aktuelle Digitalisprobleme. Schröder, R., Greeff, K. (eds.), pp. 250–256. München, Berlin, Wien: Urban & Schwarzenberg 1972
Swynghedauw, B., Corsin, A.: Les effects d’une perfusion hyper ou hypocalcique sur la glycolyse du coeur isolé de lapin. Arch. Int. Physiol. Biochim. 77, 181–205 (1969)
Szekeres, L., Lenard, G., Török, T.: Effect of strophanthine on myocardial metabolism of normal and hypoxic rats. Arch. Int. Pharmacodyn. 119, 102–109 (1959)
Tanz, R.D., Marcus, S.M.: Influence of endogenous cardiac catecholamine depletion on the force and rate of isolated heart preparations and their response to ouabain. J. Pharmacol. Exp. Ther. 151, 38–45 (1966)
Tauchert, M., Behrenbeck, D.W., Hötzel, J., Jansen, W., Niehues, B., Hilger, H.H.: Der Einfluß von Digoxin auf den myokardialen Sauerstoffverbrauch bei koronarer Herzkrankheit. Verh. Dtsch. Ges. Inn. Med. 83, 1641–1644 (1977)
Theisohn, M., Friedrich, M., Justus, P., Güttler, K., Klaus, W.: Heat production and oxygen consumption of the isolated rabbit heart: their relation to mechanical function. Basic Res. Cardiol. 72, 19–33 (1977)
Theisohn, M., Güttler, K., Klaus, W., Theisohn-Schwedhelm, I.: An improved method for simultaneous measurement of heat production and some parameters of mechanical function of isolated hearts. Naunyn-Schmiedebergs Arch. Pharmacol. 274(suppl.), R 116 (1972)
Thorn, W., Gercken, G., Härter, P.: Function, substrate supply, and metabolite content of rabbit heart perfused in situ. Am. J. Physiol. 214, 139–145 (1968)
Tsao, S.-S., Cornatzer, W.E.: Effect of digitonin and digitoxin on the phospholipid metab- olism of mammalian tissue culture cells. Biochem. Pharmacol. 16, 249–262 (1967)
Turto, H.: Experimental cardiac hypertrophy and the synthesis of poly (A) containing RNA and of myocardial proteins in the rat: The effect of digitoxin treatment. Acta Physiol. Scand. 101, 144–154 (1977)
Turto, H., Lindy, S., Uitto, J.: Effect of digitoxin on myocardial nucleic acids and total proteins in experimental cardiac hypertrophy in rats. Scand. J. Clin. Lab. Invest. 27(suppl.), 20 (1971)
Turto, H., Lindy, S.: Digitoxin treatment and experimental cardiac hypertrophy in the rat. Cardiovasc. Res. 7, 482–489 (1973)
Ueba, Y., Ito, Y., Chidsey, C.A. III.: Intracellular calcium and myocardial contractility. I. Influence of extracellular calcium. Am. J. Physiol. 220, 1553–1557 (1971)
Van der Veen, K.J., Willebrands, A.F.: Effect of frequency and Ca+ + concentration on oxy-gen consumption of the isolated rat heart. Am. J. Physiol. 212, 1536–1540 (1967)
Vernick, R., Sonnenblick, E.H., Lesch, M.: The inhibition by ouabain of phospholipid turn-over in the myocardium of the rabbit. J. Mol. Cell. Cardiol. 5, 553–557 (1973)
Wallace, A.G., Skinner, N.S. Jr., Mitchel, J.H.: Hemodynamic determinants of the maximal rate of rise of left ventricular pressure. Am. J. Physiol. 205, 30–36 (1963)
Waser, P.G., Volkart, O.: Wirkung von Herzglykosiden auf Actomyosin; Viskositätsmessungen. Heiv. Physiol. Pharmacol. Acta 12, 12–22 (1954)
Watanabe, A.M., Besch, H.R.: Cyclic adenosine monophosphate modulation of slow cal-cium influx channels in guinea pig hearts. Circ. Res. 35, 316–324 (1974)
Weber, K.T., Janicki, J.S.: Interdependence of cardiac function, coronary flow and oxygen extraction. Am. J. Physiol. 236, H784—H793 (1978)
Weber, K.T., Janicki, J.S.: The metabolic demand and oxygen supply of the heart: physiologic and clinical considerations. Am. J. Cardiol. 44, 722–729 (1979)
Weicker, B.: Stoffwechselwirkung des Strophanthins am Warmblütlerherzen. Arch. Exp. Pathol. Pharmakol. 178, 524–533 (1935)
Weissler, A.M., Gamel, W.G., Goode, H.E., Cohen, S., Schoenfeld, C.D.: The effects of digitalis on ventricular ejection in normal human subjects. Circulation 29, 721–729 (1964)
Wenzel, J., Hecht, A.: Enzymhistochemische and morphologische Befunde am Meerschweinchenherzmuskel nach Anwendung verschiedener kardiotoxischer Substanzen. Exp. Path. (Jena) 3, 305–320 (1969)
Whalen, W.J.: The relation of work and oxygen consumption on isolated strips of cat and rat myocardium. J. Physiol. (Lond.) 57, 1–17 (1961)
Willebrands, A.F., van der Veen, K.J.: Influence of substrate on oxygen consumption of isolated perfused rat heart. Am. J. Physiol. 212, 1529–1535 (1967)
Williams, A., Nayler, W.G.: High energy phosphate and total calcium concentrations during ouabain induced myocardial contractures. J. Mol. Cell. Cardiol. 9(suppl.), 64 (1977)
Williams, J F Jr, Braunwald, E.: Studies on digitalis. XI. Effects of digitoxin on the development of cardiac hypertrophy in the rat subjected to aortic constriction. Am. J. Cardiol. 16, 534–539 (1965)
Williamson, J.R.: Metabolic effects of epinephrine in the isolated, perfused rat heart. I. Dissociation of the glycogenolytic from the metabolic stimulatory effect. J. Biol. Chem. 239, 2721–2729 (1964)
Williamson, J.R.: Glycolytic control mechanisms. I. Inhibition of glycolysis by acetate and pyruvate in the isolated perfused rat heart. J. Biol. Chem. 240, 2308–2321 (1965)
Williamson, J.R.: Metabolic effects of epinephrine in the perfused rat heart. II. Control steps of glucose and glycogen metabolism. Mol. Pharmacol. 2, 206–220 (1966)
Williamson, J.R.: Mitochondrial function in the heart. Ann. Rev. Physiol. 41, 485–506 (1979)
Winter, C.G., Christensen, H.N.: Migration of amino acids across the membrane of the human erythrocyte. J. Biol. Chem. 239, 872–878 (1964)
Wollenberger, A.: Metabolic action of the cardiac glycosides. I. Influence on respiration of heart muscle and cortex. J. Pharmacol. Exp. Ther. 91, 39–51 (1947)
Wollenberger, A.: The energy metabolism of the failing heart and the metabolic action of the cardiac glycosides. Pharmacol. Rev. 1, 311–352 (1949)
Wollenberger, A.: Effect of ouabain on the utilization of 14C-labelled glucose and pyruvate by cardiac muscle. J. Pharmacol. Exp. Ther. 101, 38–39 (1951a)
Wollenberger, A.: Utilization of 14C-labelled glucose by cardiac muscle treated with a cardiac glycoside. Science 113, 64–65 (1951b)
Wollenberger, A.: Metabolic action of the cardiac glycosides. II. Effects of ouabain and digoxin on the energy-rich phosphate content of the heart. J. Pharmacol. Exp. Ther. 103, 123–125 (1951c)
Wollenberger, A.: Metabolic action of cardiac glycosides. III. Influence of ouabain on the utilization of 14C-labelled glucose, lactate, and pyruvate by dog heart slices. Arch. Exp. Pathol. Pharmakol. 219, 408–419 (1953)
Wollenberger, A.: Introduction of agents influencing myocardial contraction: cardiac glycosides. In: Factors influencing myocardial contractility. Tanz, R.D., Kavaler, F., Roberts, R. (eds.), pp. 506–518. New York: Academic Press 1967
Wollenberger, A., Jehl, J., Karsh, M.L.: Influence of age on the sensitivity of the guinea pig and its myocardium to ouabain. J. Pharmacol. Exp. Ther. 108, 52–60 (1953)
Wood, J.M., Crow, C.A., Schwartz, A.: Ouabain-induced respiratory changes in guinea pig heart tissue: requirement for calcium. Acta Biol. Med. Germ. 28, 901–917 (1972)
Wood, J.M., Schwartz, A.: Ouabain-induced respiratory changes in guinea-pig heart tissue: relation of Ca+ + in the medium. Pharmacologist 12, 266 (1970)
Yankopoulos, N.A., Kawai, C., Federici, E.E.: The hemodynamic effects of ouabain upon the diseased left ventricle. Am. Heart J. 76, 466–480 (1968)
Yu, D.H., Triester, S., Gluckman, M.I.: The mechanism of antilipolytic activity of cardioactive drugs in rats. Pharmacologist 11, 238 (1969)
Yu, D.H., Triester, S., Gluckman, M.I.: Mechanism of antilipolytic effects of cardiac glycosides. J. Pharmacol. Exp. Ther. 177, 284–290 (1971)
Yu, D.H., Triester, S.: Further studies of the possible mechanism of action of cardiac glycosides on lipolysis. Fed. Proc. 31, 525 (1972)
Yunis, A.A., Arimura, G.K.: Amino acid transport in blood cells. II. Patterns of transport of some amino acids in mammalian reticulocytes and mature red blood cells. J. Lab. Clin. Med. 66, 177–186 (1965)
Yusuf, S.M., Gans, J.H.: In vitro metabolism of atrial and ventricular myocardium: effect of ouabain. Arch. Int. Pharmacodyn. 160, 188–195 (1966a)
Yusuf, S.M., Gans, J.H.: In vitro metabolism of atrial and ventricular myocardium from reserpine treated dogs: effect of ouabain. Arch. Int. Pharmacodyn. 160, 196–203 (1966b)
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1981 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Güttler, K., Klaus, W. (1981). Influence of Cardiac Glycosides on Myocardial Energy Metabolism. In: Greeff, K. (eds) Cardiac Glycosides. Handbook of Experimental Pharmacology, vol 56 / 1. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-68163-9_13
Download citation
DOI: https://doi.org/10.1007/978-3-642-68163-9_13
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-68165-3
Online ISBN: 978-3-642-68163-9
eBook Packages: Springer Book Archive